Published On: Wed, Oct 19th, 2016

LeMaitre Vascular, Inc. (LMAT) Updated Analyst Coverage


A number of investment brokers have recently updated their price targets on shares of LeMaitre Vascular, Inc. (LMAT).

Most recent broker ratings

09/22/2016 – LeMaitre Vascular, Inc. was downgraded to “neutral” by analysts at Sidoti. They now have a USD 23 price target on the stock.

07/28/2016 – LeMaitre Vascular, Inc. had its “outperform” rating reiterated by analysts at Barrington Research. They now have a USD 20 price target on the stock.

07/28/2016 – LeMaitre Vascular, Inc. had its “buy” rating reiterated by analysts at Brean Capital. They now have a USD 20 price target on the stock.

05/03/2016 – LeMaitre Vascular, Inc. had its “buy” rating reiterated by analysts at Canaccord Genuity. They now have a USD 18 price target on the stock.

05/03/2016 – LeMaitre Vascular, Inc. had its “buy” rating reiterated by analysts at Roth Capital. They now have a USD 18.5 price target on the stock.

12/07/2015 – LeMaitre Vascular, Inc. had its “buy” rating reiterated by analysts at Dougherty & Co. They now have a USD 19 price target on the stock.

12/04/2015 – LeMaitre Vascular, Inc. had its “buy” rating reiterated by analysts at Stifel Nicolaus. They now have a USD 17 price target on the stock.

07/29/2015 – LeMaitre Vascular, Inc. had its “buy” rating reiterated by analysts at Benchmark. They now have a USD 14 price target on the stock.

04/30/2015 – LeMaitre Vascular, Inc. was downgraded to “buy” by analysts at Zacks. They now have a USD 10 price target on the stock.

05/19/2014 – ING began new coverage on LeMaitre Vascular, Inc. giving the company a “buy” rating. They now have a USD 11 price target on the stock.

05/16/2014 – LeMaitre Vascular, Inc. was downgraded to “hold” by analysts at TheStreet.

The share price of LeMaitre Vascular, Inc. (LMAT) was up +2.13% during the last day of trading, with a day high of 19.80. 98467 shares were traded during the last session.

The stock’s 50 day moving average is 20.07 and its 200 day moving average is 16.68. The stock’s market capitalization is 362.26M. LeMaitre Vascular, Inc. has a 52-week low of 12.03 and a 52-week high of 22.50.

LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company and its subsidiaries develop, manufacture and market medical devices and implants used primarily in the field of vascular surgery. It operates in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company’s product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.